Montana’s seven day cap expired.The replacement should protect judgment, not revive a number.
Montana’s restriction on initial outpatient opioid prescriptions for opioid naive patients carried a June 30, 2025 termination date and included a chronic pain exception. The next durable law should preserve that distinction, protect individualized treatment, and make continuity enforceable without weakening monitoring or professional responsibility.
A sunset creates an opening for a better law.
Montana’s former seven day rule was narrow, temporary, and expressly subject to professional judgment for chronic pain. The state should not leave patients and clinicians with stale summaries or rebuild the same rule. It should enact a clear chronic pain and continuity standard.
Name the instrument before judging the effect.
An expired prescribing limit, an active prescription registry duty, Medicaid prior authorization, professional discipline, and an institutional dosage policy are different instruments. Montana’s public record should make those boundaries unmistakable.
Former seven day limit
MCA 37 2 108 restricted an initial outpatient opioid prescription for an opioid naive patient and contained a chronic pain exception. Its text carried a June 30, 2025 termination date.
MPDR review
MCA 37 7 1515 generally requires review before an opioid or benzodiazepine prescription, with stated exceptions and a three month review interval for chronic pain treatment.
Montana Medicaid
The preferred drug list and prior authorization criteria govern payment. Coverage rules do not automatically define the professional standard of care.
The old law contained three facts worth preserving accurately.
Initial outpatient limit
The restriction applied to an opioid naive patient, not every patient or every prescription.
Chronic pain exception
A longer prescription was permitted when the prescriber’s professional medical judgment found it necessary for chronic pain, cancer pain, or palliative care.
Express termination
The section carried a statutory termination date of June 30, 2025. Historical summaries should not present that temporary limit as current law.
The next law should protect treatment, not guarantee a prescription.
Good faith individualized care
A stable chronic pain patient should not lose treatment solely because of an MME threshold, duration, diagnosis label, or a policy detached from the patient’s actual record.
Patient specific judgment
A prescriber or pharmacist may act on a documented concern involving medical purpose, serious harm, unsafe combination, diversion, identity, or another lawful patient specific reason.
Information, not adjudication
The MPDR supplies prescription history for coordination and safety. A database entry does not alone establish misuse, diversion, diagnosis, or the proper treatment.
Payment, not discipline
Montana Medicaid may apply prior authorization and preferred drug criteria. A coverage decision is not itself a finding of unlawful or unprofessional care.
Replace the expired cap with a continuity law.
- Confirm in the published code and agency materials that the former seven day opioid naive restriction terminated on June 30, 2025.
- Enact a replacement chronic pain section protecting good faith treatment and professional judgment from discipline based solely on dosage or duration.
- Prohibit a required taper, refusal, discharge, coverage denial, or pharmacy policy based solely on an MME threshold when a stable patient is not experiencing serious harm.
- Require a written, patient specific reason and prompt clinical review for an adverse decision affecting established treatment.
- Require a transition plan, appropriate bridge care, records transfer, and direct referral when a clinician cannot continue care.
- Publish aggregate data on discontinuations, tapers, pharmacy refusals, prior authorization, reviews, reversals, wait times, and rural access.
Give Montana text it can adopt.
A health care provider acting in good faith and for a legitimate medical purpose shall not be subject to discipline solely because treatment for a diagnosed chronic pain condition exceeds a dosage or duration recommendation contained in a guideline or policy. Dosage recommendations inform but do not replace individualized clinical judgment.
An established patient who is stable, follows the treatment plan, and is not experiencing serious harm shall not be required to taper or lose treatment solely to meet a predetermined MME threshold. An adverse decision must state a patient specific reason and provide prompt review and a clinically appropriate transition.
Turn the sunset into a clean public record.
Correct every public summary
Identify state pages, presentations, manuals, training, payer documents, and clinic policies that still describe the former limit without its termination date.
Publish baseline data
Measure chronic pain access, provider loss, forced tapering, pharmacy refusal, authorization delay, treatment interruption, and rural travel burden.
Hear Montana communities
Take testimony from patients, tribal communities, rural clinicians, pharmacists, plans, disability advocates, regulators, and recovery specialists.
Enact the replacement
Protect individualized care and continuity while preserving records, registry use, consultation, naloxone, and patient specific safety judgment.
Audit the outcome
Publish implementation, complaints, review times, reversals, continuity, emergency care, overdose, suicide risk, and regional access.
Make the current law and its effects visible.
Send each correction to its owner.
| Authority | Instrument | Proper request |
|---|---|---|
| Montana Legislature | MCA 37 2 108 replacement | Enact individualized chronic pain, continuity, notice, and review protections. |
| Board of Medical Examiners | Rules, guidance, and discipline | Distinguish current law from expired limits and protect good faith clinical judgment. |
| Board of Pharmacy | MPDR and pharmacy practice | Preserve registry review while requiring patient specific reasons and direct communication. |
| Department of Public Health and Human Services | Public health and Montana Medicaid | Correct dated materials and align coverage review with individualized care. |
| Health systems, plans, and pharmacies | Operating policy | Remove stale caps, document actual reasons, and maintain safe continuity. |
Montana already recognized the essential distinctions.
Keep the exception principle
The former law recognized that chronic pain may require treatment beyond a short initial supply and left that determination to professional medical judgment.
Keep the record available
The active MPDR requirement supports coordination and safety, including periodic review for ongoing chronic pain treatment.
Keep criteria public
Montana Medicaid publishes its preferred drug list, authorization contacts, and program materials. The next step is outcome transparency and continuity measurement.
Open the controlling documents.
Precision protects the reform.
What the record supports
- The former restriction applied to initial outpatient prescribing for an opioid naive patient.
- It exempted chronic pain, cancer pain, and palliative care when professional judgment supported a longer supply.
- The published section carried a June 30, 2025 termination date.
- Montana’s separate MPDR review requirement remains an active safety instrument.
What the record does not establish
- Montana currently limits every opioid prescription to seven days.
- The former rule governed every established chronic pain patient.
- A registry entry alone proves misuse, diversion, or improper care.
- Replacing the expired limit requires abandoning monitoring or professional standards.
This Atlas is public policy education and source mapping, not legal advice or individual medical advice. Patients should not abruptly change medication or treatment based on this page.
Do not revive an expired number. Write a durable standard for the person.
Montana can preserve registry review and professional responsibility while protecting individualized chronic pain care, safe continuity, and accountable decisions.